CCCC vs CE · rev $35.6M vs rev $10.28B
C4 Therapeutics Inc (CCCC) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
CCCC currently screens at market cap $425.7M. CE currently screens at market cap $5.92B.
Not investment advice. Open the CCCC and CE stock pages for the full models.
Not investment advice.